These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2101530)

  • 1. [Reproductive variables and risk of benign breast diseases. A case-control study].
    Hardy EE; Pinotti JA; Osis MJ; Faúndes A
    Rev Saude Publica; 1990 Oct; 24(5):387-93. PubMed ID: 2101530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use and risk of benign breast disease in a French case-control study of young women.
    Charreau I; Plu-Bureau G; Bachelot A; Contesso G; Guinebretiére JM; Lê MG
    Eur J Cancer Prev; 1993 Mar; 2(2):147-54. PubMed ID: 8461865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive and hormonal factors and breast cancer in a Northern Italian population.
    Talamini R; La Vecchia C; Franceschi S; Colombo F; Decarli A; Grattoni E; Grigoletto E; Tognoni G
    Int J Epidemiol; 1985 Mar; 14(1):70-4. PubMed ID: 3988443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics that predict risk of breast cancer before and after the menopause.
    Paffenbarger RS; Kampert JB; Chang HG
    Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for benign breast disease: a case-control study of discordant twins.
    Odenheimer DJ; Zunzunegui MV; King MC; Shipler CP; Friedman GD
    Am J Epidemiol; 1984 Oct; 120(4):565-71. PubMed ID: 6540984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for benign breast disease: a 30-year cohort study.
    Hislop TG; Elwood JM
    Can Med Assoc J; 1981 Feb; 124(3):283-91. PubMed ID: 7459788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of oral contraceptive use and risk of benign breast disease.
    Rohan TE; Miller AB
    Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and breast disease.
    McGonigle KF; Huggins GR
    Fertil Steril; 1991 Nov; 56(5):799-819. PubMed ID: 1936311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.
    Plu-Bureau G; Thalabard JC; Sitruk-Ware R; Asselain B; Mauvais-Jarvis P
    Br J Cancer; 1992 Jun; 65(6):945-9. PubMed ID: 1616869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and breast cancer: review of the epidemiologic literature.
    Thomas DB
    Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and premenopausal breast cancer in nulliparous women.
    Stadel BV; Lai SH; Schlesselman JJ; Murray P
    Contraception; 1988 Sep; 38(3):287-99. PubMed ID: 3168449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.